Bloomberg Businessweek (Asia)

Avonex

-

Biogen has been ratcheting down discounts on Avonex as demand declines and it focuses on its newer multiple sclerosis medicines. The result: The afterdisco­unt price has more than tripled in six years.

 ??  ??

Newspapers in English

Newspapers from Australia